Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1: results from a randomized trial
Ernest Asante‐Appiah, И. М. Хаертынова, Todd Correll, Andrew Carr et al.
Journal
AIDS
Topics
HIV Research and Treatment
article
Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1: results from a randomized trial
Ernest Asante‐Appiah, И. М. Хаертынова, Todd Correll, Andrew Carr, Princy Kumar, Rosie Mngqibisa, Ying Zhang, Wayne L. Greaves, Shariq Haider
article en
Abstract
No abstract available for this paper.
Publication Tag
AIDSVol. 40(2)
Institutions
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Georgetown University (US), St Vincent's Hospital Sydney (AU), Kazan State Medical Academy (RU), King Edward VIII Hospital (ZA), McMaster University (CA)